Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$104.71 USD
-2.19 (-2.05%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $103.90 -0.81 (-0.77%) 4:42 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Mesa Labs (MLAB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$118.00 | $130.00 | $106.00 | 10.38% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Mesa Labs comes to $118.00. The forecasts range from a low of $106.00 to a high of $130.00. The average price target represents an increase of 10.38% from the last closing price of $106.90.
Analyst Price Targets (2 )
Broker Rating
Mesa Labs currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, two are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/4/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
10/16/2023 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 3 |
Average Target Price | $118.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 101 of 253 |
Current Quarter EPS Est: | 2.33 |